Log In
Print
BCIQ
Print
Print this Print this
 

Sym004

  Manage Alerts
Collapse Summary General Information
Company Symphogen A/S
DescriptionCombination of 2 anti-EGFR mAbs against 2 distinct and non-overlapping epitopes in the extracellular domain III of EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today